DexCom
DXCM
#786
Rank
A$45.83 B
Marketcap
A$118.78
Share price
11.95%
Change (1 day)
-4.79%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2026 (TTM): A$1.82 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.81 Billion. In 2025 the company made an earning of A$1.57 Billion, an increase over its 2024 earnings that were of A$1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.82 B15.7%
2025 A$1.57 B52.02%
2024 A$1.03 B-0.37%
2023 A$1.04 B78.13%
2022 A$0.58 B47.34%
2021 A$0.39 B-10.11%
2020 A$0.44 B88.27%
2019 A$0.23 B-258.48%
2018 -A$0.15 Billion189.94%
2017 -A$50.96 Million-44.24%
2016 -A$91.39 Million12.43%
2015 -A$81.28 Million165.58%
2014 -A$30.61 Million-25.61%
2013 -A$41.14 Million-48.11%
2012 -A$79.28 Million24.5%
2011 -A$63.68 Million
2008 -A$75.2 Million13.18%
2007 -A$66.44 Million-5.36%
2006 -A$70.21 Million52.08%
2005 -A$46.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.97 B 2,028.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.58 B 566.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.75 B 461.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$2.34 B 34.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$1.99 B 14.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.14 Billion-108.04%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.68 Billion-196.57%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$0.95 B-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA